Unisun Energy Group Completes Series C Financing
Unisun Energy Group, a Shanghai, China-based provider of industrial and commercial intelligent green power services, raised an undisclosed amount in Series C funding.
Unisun Energy Group, a Shanghai, China-based provider of industrial and commercial intelligent green power services, raised an undisclosed amount in Series C funding.
Atantares, a Beijing, China-based developer of develop molecular chips, closed a Pre-A and Pre-A+ financing all around RMB100m.
Panlin Capital, a Shangai, China-based venture capital firm focusing on Chinese technological innovation, closed its 12th RMB-denominated main fund.
Detection Technology, an Espoo, Finland-based provider of X-ray detector solutions and services, acquired Haobo Imaging, a Shanghai, China-based company which specializes in static and dynamic TFT flat panel detectors.
Eccogene, a Shanghai, China-based clinical-stage biotechnology company, raised CNY180M (approx. $25M) in Series B Equity funding.
Lynk Pharmaceuticals, a Hangzhou, China-based clinical stage company, raised 200M RMB in Series C1 funding.
LTZ Therapeutics, a Redwood City, CA- and Shenzen, China-based immunotherapy-focused biotech company, raised over $10m in pre-A+ financing.
Cloudsky Technologies, a Shenzen, China-based computing infrastructure and services provider, secured a Series C+ round funding of no less than ten million dollars.
AutoCore.ai, a Nanjing, China-based automotive system software provider, completed its A+ round funding.
ChomiX Biotech, a Nanjing, China-based biotechnology company focusing on the preclinical development of innovative small molecule drugs, raised an undisclosed amount in Series Pre-A+ funding.
ecoSPIRITS, a Singapore-based circular economy technology company focusing on low carbon, low waste distribution systems for the premium wine and spirits industry, raised $10M in Series A funding.
Cullgen, Inc., a San Diego, CA and Shangai, China-based biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, raised $40m in funding.
Pudu Robotics, a Shenzhen, China-based company which specializes in commercial service robots, raised hundreds of millions of yuan in its C4 financing round.
Adcentrx Therapeutics, a San Diego, CA and Shangai, China-based biotechnology company dedicated to advancing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-threatening diseases, closed a $38m Series A+ financing.
Ankura Consulting Group, a London, UK-based independent services and advisory firm, acquired GreenPoint Group, a US-China strategic advisory firm focused on corporations and non-profit organizations.